Leveraging Latin assets in clinical trials

Good Clinical Practice Journal

Volumn 13, Issue 3, 2006, Pages 16-19

  Hurley, Dennis ^a  

^a NONE

Author keywords

Emerging markets; Hispanics; Outsourcing; Regulatory timelines

Indexed keywords

DRUG;

ARGENTINA; ARTICLE; BRAZIL; CHILE; CHINA; CLINICAL RESEARCH; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; EUROPEAN UNION; FINANCIAL MANAGEMENT; GOOD CLINICAL PRACTICE; HUMAN; MANAGEMENT; MEXICO; PATIENT PARTICIPATION; PERU; PROFESSIONAL STANDARD; SAMPLE SIZE; SOUTH AND CENTRAL AMERICA;

EID: 33644825403     PISSN: 13500961     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. KA Getz. 'A swift predominance of ex-US sites', Applied Clinical Trials, 14(12), pp21-22, 2005.
2. Anon. 'Pharma needs you', Next Generation Pharmaceutical, December, pp76-78, 2005 (www.ngpharma.com/pastissue/ article.asp?art=25520&issue=143).
3. J Jones. 'Maximising patient recruitment', Scrip Supplement: Focus on Patient Recruitment, pp3-4, October, 2005.
4. S Gambrill. 'Top 20 pharma flock to China, set up CRUs', CenterWatch Monthly, 13(1), p 6-9, January, 2006.
5. S Gambrill. 'China on fast track to becoming developed market', CenterWatch Monthly, 12(12), pp6-11, December, 2005.
6. G Pei. 'China's growing clinical culture', Good Clinical Practice Journal, 12(7), pp11-13, 2005.
7. M Wren. 'Well-connected for e-trials', Good Clinical Practice Journal, 10(3), p16, 2003.